Maravai Lifesciences Holdings, Inc. (MRVI)
7.90
+0.40
(+5.33%)
USD |
NASDAQ |
Oct 02, 16:00
7.87
-0.03
(-0.38%)
After-Hours: 20:00
Maravai Lifesciences Holdings Shareholders Equity (Quarterly) : 204.62M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 204.62M |
| March 31, 2026 | 211.56M |
| December 31, 2025 | 212.38M |
| September 30, 2025 | 245.44M |
| June 30, 2025 | 265.86M |
| March 31, 2025 | 300.61M |
| December 31, 2024 | 325.29M |
| September 30, 2024 | 345.14M |
| June 30, 2024 | 436.93M |
| March 31, 2024 | 410.66M |
| December 31, 2023 | 416.75M |
| September 30, 2023 | 519.29M |
| June 30, 2023 | 520.57M |
| March 31, 2023 | 521.52M |
| Date | Value |
|---|---|
| December 31, 2022 | 545.22M |
| September 30, 2022 | 503.76M |
| June 30, 2022 | 456.59M |
| March 31, 2022 | 382.56M |
| December 31, 2021 | 315.50M |
| September 30, 2021 | 302.64M |
| June 30, 2021 | 193.92M |
| March 31, 2021 | 112.61M |
| December 31, 2020 | 88.51M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 141.40M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp. | 2.112B |
| Bio-Techne Corp. | 2.108B |
| BioLife Solutions, Inc. | 420.00M |
| MindWalk Holdings Corp. | 4.926M |
| MaxCyte, Inc. | 158.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 603.75M |
| Total Liabilities (Quarterly) | 248.16M |
| Debt to Equity Ratio | 0.8635 |
| Current Ratio | 4.052 |
| Net Debt Paydown Yield | 3.23% |